CheckMyRecalls

Unichem Pharmaceuticals USA Inc. recalls Doxazosin Tablets

Published
18 Feb 2026
Units affected
60,000 tablets
Agency
FDA
Country
United States

The hazard

Tablets/Capsules Imprinted with Wrong ID

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10.

Brand / company
Unichem Pharmaceuticals USA Inc.
Codes / lots
Lot # GDSH25006, Exp Date: 08/2027
Distribution
Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 18 Feb 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.